YMAB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Y-mAbs Therapeutics (YMAB) Earnings Date & Reports

Industry: @Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

YMAB is expected to report earnings to fall 29.00% to -14 cents per share on November 08

Y-mAbs Therapeutics YMAB Stock Earnings Reports

Q3'24

Est.

$-0.15

Q2'24

Missed

by $0.09

Q1'24

Missed

by $0.01

Q4'23

Beat

by $0.18

Q3'23

Beat

by $0.01

The last earnings report on August 12 showed earnings per share of -20 cents, missing the estimate of -11 cents. With 75.64K shares outstanding, the current market capitalization sits at 662.75M.

View a ticker or compare two or three

Compare

YMAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For YMAB
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for YMAB (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

230 Park Avenue

Phone

+1 646 885-8505

Employees

100

Web

https://www.ymabs.com